Sokolov J. Jacque's most recent trade in Lucid Diagnostics Inc was a trade of 112,800 Common Stock done . Disclosure was reported to the exchange on Feb. 20, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Lucid Diagnostics Inc | Jacque J. Sokolov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 112,800 | 197,460 | - | 0 | Common Stock | |
Lucid Diagnostics Inc | Sokolov J. Jacque | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 150,000 | 150,000 | - | - | Employee stock option (right to buy) | |
Lucid Diagnostics Inc | Jacque J. Sokolov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 175,000 | 175,000 | - | - | Employee stock option (right to buy) | |
Lucid Diagnostics Inc | Jacque J. Sokolov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 59,000 | 59,000 | - | - | Employee stock option (right to buy) |